Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Matilde Bocci
Observed names:
Bocci, Matilde,
M. Bocci
Institution:
Philochem (Switzerland)
Observed institutions:
University of Pavia,
Philochem (Switzerland)
ORCID:
0000-0003-0317-4535
Observed ORCID:
0000-0003-0317-4535
OpenAlex ID:
A5037557607
A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake
2022
·
Andrea Galbiati
, Aureliano Zana
, et al.
·
Journal of Nuclear Medicine
·
87
PDF
Preclinical Evaluation of 177 Lu-OncoFAP-23, a Multivalent FAP-Targeted Radiopharmaceutical Therapeutic for Solid Tumors
2024
·
Andrea Galbiati
, Matilde Bocci
, et al.
·
Journal of Nuclear Medicine
·
44
PDF
A Comparative Analysis of Fibroblast Activation Protein-Targeted Small Molecule–Drug, Antibody–Drug, and Peptide–Drug Conjugates
2023
·
Aureliano Zana
, Claudia Puig-Moreno
, et al.
·
Bioconjugate Chemistry
·
35
In vivo activation of FAP-cleavable small molecule-drug conjugates for the targeted delivery of camptothecins and tubulin poisons to the tumor microenvironment
2024
·
Matilde Bocci
, Aureliano Zana
, et al.
·
Journal of Controlled Release
·
34
Molecular Evolution of Multivalent OncoFAP Derivatives with Enhanced Tumor Uptake and Prolonged Tumor Retention
2024
·
Andrea Galbiati
, Matilde Bocci
, et al.
·
Journal of Medicinal Chemistry
·
31
Fibroblast Activation Protein Triggers Release of Drug Payload from Non-internalizing Small Molecule Drug Conjugates in Solid Tumors
2022
·
Aureliano Zana
, Andrea Galbiati
, et al.
·
Clinical Cancer Research
·
30
Tumor-Targeted Interleukin 2 Boosts the Anticancer Activity of FAP-Directed Radioligand Therapeutics
2023
·
Andrea Galbiati
, Paulina Dorten
, et al.
·
Journal of Nuclear Medicine
·
18
PDF
Effect of molar dose on the in vivo tissue biodistribution profile of FAP-targeted radioligand therapeutics
2024
·
Andrea Galbiati
, Matilde Bocci
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
11
DNA-encoded chemical libraries enable the discovery of potent PSMA-ligands with substantially reduced affinity towards the GCPIII anti-target
2024
·
Laura Lucaroni
, Sebastian Oehler
, et al.
·
Chemical Science
·
8
Ex vivo mass spectrometry-based biodistribution analysis of an antibody-Resiquimod conjugate bearing a protease-cleavable and acid-labile linker
2023
·
Lydia Bisbal Lopez
, Domenico Ravazza
, et al.
·
Frontiers in Pharmacology
·
7
Delivery of Monomethyl Auristatin F to the Tumor Microenvironment with Noninternalizing Fibroblast Activation Protein-Cleavable Small Molecule–Drug Conjugates Elicits Potent In Vivo Anticancer Activity
2024
·
Matilde Bocci
, Lucrezia Principi
, et al.
·
Bioconjugate Chemistry
·
6
Development of Multivalent FAP-Targeted Small Molecule–Drug Conjugates with Tailored MMAE Release Kinetics
2025
·
Matilde Bocci
, Lucrezia Principi
, et al.
·
Molecular Cancer Therapeutics
·
5
Combinatorial treatment with upadacitinib abrogates systemic toxicity of a tumor-targeted IL-2 fusion protein
2025
·
Giulia Rotta
, Eleonora Prodi
, et al.
·
Journal for ImmunoTherapy of Cancer
·
5
A Small-Molecule Drug Conjugate Targeting FAP Exhibits Potent Activity in Dogs with Spontaneous Tumors
2026
·
Andrea Galbiati
, Paola Roccabianca
, et al.
·
Journal of Medicinal Chemistry
·
3
Combination with Immunocytokines Enhances the Anticancer Activity of Small Molecule Drug Conjugates and Radioligand Therapeutics Targeting Fibroblast Activation Protein
2026
·
Matilde Bocci
, Laura Lucaroni
, et al.
·
Molecular Pharmaceutics
·
3
Expression patterns of fibroblast activation protein and extra-domain B fibronectin in canine malignant tumors
2026
·
Silvia Dell’Aere
, Elisa Maria Gariboldi
, et al.
·
Frontiers in Veterinary Science
·
1
PDF
Abstract 4312: FAP-targeting Small molecule-immunostimulator conjugate bearing a novel TLR7 agonist payload induces tumor eradication and long-lasting antitumor immunity in vivo
2026
·
Matilde Bocci
, Matilde Monaci
, et al.
·
Cancer Research
Supplementary Appendix S1 from Fibroblast Activation Protein Triggers Release of Drug Payload from Non-internalizing Small Molecule Drug Conjugates in Solid Tumors
2025
·
Aureliano Zana
, Andrea Galbiati
, et al.
Figure S4 from Development of Multivalent FAP-Targeted Small Molecule–Drug Conjugates with Tailored MMAE Release Kinetics
2025
·
Matilde Bocci
, Lucrezia Principi
, et al.
Figure S2 from Development of Multivalent FAP-Targeted Small Molecule–Drug Conjugates with Tailored MMAE Release Kinetics
2025
·
Matilde Bocci
, Lucrezia Principi
, et al.
Supplementary Information from Development of Multivalent FAP-Targeted Small Molecule–Drug Conjugates with Tailored MMAE Release Kinetics
2025
·
Matilde Bocci
, Lucrezia Principi
, et al.
Figure S5 from Development of Multivalent FAP-Targeted Small Molecule–Drug Conjugates with Tailored MMAE Release Kinetics
2025
·
Matilde Bocci
, Lucrezia Principi
, et al.
Figure S1 from Development of Multivalent FAP-Targeted Small Molecule–Drug Conjugates with Tailored MMAE Release Kinetics
2025
·
Matilde Bocci
, Lucrezia Principi
, et al.
Data from Development of Multivalent FAP-Targeted Small Molecule–Drug Conjugates with Tailored MMAE Release Kinetics
2025
·
Matilde Bocci
, Lucrezia Principi
, et al.
Figure S3 from Development of Multivalent FAP-Targeted Small Molecule–Drug Conjugates with Tailored MMAE Release Kinetics
2025
·
Matilde Bocci
, Lucrezia Principi
, et al.
Show more works
View as search
Works count:
38
Citation count:
328
H-index:
8
I10-index:
8
Year
Topic
Type
